NCT01548040View on ClinicalTrials.gov

Controlled Study of Kneehab XP for Patients Undergoing Total Knee Replacement

NACompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

August 31, 2016

Study Completion Date

October 31, 2016

Conditions
Total Knee Replacement
Interventions
DEVICE

Kneehab XP

NMES using Kneehab XP on the affected leg,20 minutes, twice per day, 5 days a week. Subjects will begin use of the device at 6 weeks pre-operatively and continue through 6 weeks post-operatively

DEVICE

Quadriceps TENS

on the affected leg, 20 minutes, twice per days, 5 days a week. Subjects will begin use of the device at 6 weeks pre-operatively and continue through 6 weeks post-operatively.

Trial Locations (1)

29615

Hawkins Foundation, Greenville

All Listed Sponsors
lead

Theragen Inc.

INDUSTRY

NCT01548040 - Controlled Study of Kneehab XP for Patients Undergoing Total Knee Replacement | Biotech Hunter | Biotech Hunter